Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Coma from the health food store: interaction between kava and alprazolam.

Almeida JC, Grimsley EW.

Ann Intern Med. 1996 Dec 1;125(11):940-1. No abstract available.

PMID:
8967683
2.

Kava: Piper methysticum.

Pepping J.

Am J Health Syst Pharm. 1999 May 15;56(10):957-8, 960. Review. No abstract available.

PMID:
10365719
3.

Sebotropic drug reaction resulting from kava-kava extract therapy: a new entity?

Jappe U, Franke I, Reinhold D, Gollnick HP.

J Am Acad Dermatol. 1998 Jan;38(1):104-6. No abstract available.

PMID:
9448214
4.

Kava: a comprehensive review of efficacy, safety, and psychopharmacology.

Sarris J, LaPorte E, Schweitzer I.

Aust N Z J Psychiatry. 2011 Jan;45(1):27-35. doi: 10.3109/00048674.2010.522554. Epub 2010 Nov 15. Review.

PMID:
21073405
5.

Piper methysticum (kava kava).

[No authors listed]

Altern Med Rev. 1998 Dec;3(6):458-60.

6.

Therapeutic potential of kava in the treatment of anxiety disorders.

Singh YN, Singh NN.

CNS Drugs. 2002;16(11):731-43. Review.

PMID:
12383029
7.

Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).

Anke J, Ramzan I.

J Ethnopharmacol. 2004 Aug;93(2-3):153-60. Review.

PMID:
15234747
8.

Kava (Piper methysticum).

[No authors listed]

J Soc Integr Oncol. 2009 Fall;7(4):170-2. No abstract available.

PMID:
19883532
9.

Kava.

[No authors listed]

Harv Womens Health Watch. 1998 Aug;5(12):6. No abstract available.

PMID:
9713242
10.

Galactorrhoea induced by a pharmacodynamic interaction between citalopram, alprazolam and tramadol: a case report.

Bondolfi G, Rubin C, Bryois C, Eap CB.

Therapie. 1997 Jan-Feb;52(1):76-7. No abstract available.

PMID:
9183928
11.

The health and social effects of drinking water-based infusions of kava: a review of the evidence.

Rychetnik L, Madronio CM.

Drug Alcohol Rev. 2011 Jan;30(1):74-83. doi: 10.1111/j.1465-3362.2010.00184.x. Review.

PMID:
21219501
12.

Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases.

Teschke R, Schwarzenboeck A, Hennermann KH.

Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1182-93. doi: 10.1097/MEG.0b013e3283036768.

PMID:
18989142
13.

Kava and alcohol.

Cantor C.

Med J Aust. 1997 Nov 17;167(10):560. No abstract available.

PMID:
9397054
14.

Kava and dopamine antagonism.

Schelosky L, Raffauf C, Jendroska K, Poewe W.

J Neurol Neurosurg Psychiatry. 1995 May;58(5):639-40. No abstract available.

15.

[Kava-kava preparations--alternative anxiolytics].

Nowakowska E, Ostrowicz A, Chodera A.

Pol Merkur Lekarski. 1998 Mar;4(21):179-180a. Review. Polish.

PMID:
9640076
16.

[Hematogenous contact eczema cause by phytogenic drugs exemplified by kava root extract].

Süss R, Lehmann P.

Hautarzt. 1996 Jun;47(6):459-61. German.

PMID:
8767662
17.

[Drug therapy of panic disorders. Kava-specific extract WS 1490 compared to benzodiazepines].

[No authors listed]

Nervenarzt. 1994 Jan;65(1 Suppl):1-4. German. No abstract available.

PMID:
9218056
18.

Kava: an herbal sedative.

Kinder C, Cupp MJ.

Nurse Pract. 1998 Jun;23(6):14, 156. Review. No abstract available.

PMID:
9656257
19.

[Piper methysticum (kava) under discussion: observations on quality, effectiveness and safety].

Schmidt M, Nahrstedt A, Lüpke NP.

Wien Med Wochenschr. 2002;152(15-16):382-8. Review. German.

PMID:
12244883
20.

Alprazolam withdrawal delirium: a case report.

Zalsman G, Hermesh H, Munitz H.

Clin Neuropharmacol. 1998 May-Jun;21(3):201-2. Review.

PMID:
9617514
Items per page

Supplemental Content

Write to the Help Desk